Advanced Relays

Evolving the relationship between developers, regulators, payers, providers and patients to speed ATMP development through to adoption. How healthy are the Technology Assessments for ATMPs, are they revealing the full value?


STEVE McCONCHIE | Chief Executive Officer | Aptus Clinical


FIONA THISTLETHWAITE | Medical Oncology Consultant | The Christie NHS Foundation Trust
BILL SHINGLETON | Department Director, Biology – Cell & Gene Therapy | Cytiva
STEPHEN LITTLE | Vice Chairman | Yourgene Health
ANTHONY WILSON | Consultant in Anaesthesia and Critical Care | Manchester University NHS Foundation Trust
CLARE HAGUE Therapy Area Market Access Leader for Hematology | Janssen (a Johnson & Johnson company)